Published: Fri, November 16, 2018
Medicine | By Brett Sutton

Blood pressure medication recall due to cancer concerns

Blood pressure medication recall due to cancer concerns

The recall includes one lot of Sandoz's losartan potassium hydrochlorothiazide 100 milligram/25 milligram tablets with the lot number JB8912. It does not take into account the other versions of the drug, which sometimes gets sold under the brand name Hyzaar.

Patients are advised to speak to their physician or healthcare provider if they happen to take the recalled blood pressure drugs.

Last week, there was another recall of a blood pressure medication that has a risk of causing cancer. This is a suspected human as well as an animal carcinogen, which is used in gasoline as a stabilizer for industrial materials and also as a lubricant additive. The FDA made that decision after an inspection of the facility.


The FDA recently recalled blood pressure drug irbesartan for the same defect. The US Environmental Protection Agency considers this as a possible carcinogen.

The FDA is testing all heart drugs known as ARBs for these impurities. It is not that all the medicines, which carry valsartan in them, are recalled. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them.

"When we identify lapses in the quality of drugs and problems with their manufacturing that have the potential to create risks to patients, we're committed to taking swift action to alert the public and help facilitate the removal of the products from the market", FDA commissioner Dr. Scott Gottlieb said back in July. Jeffrey has worked with multiple media houses and is now leading a team of journalists, sub-editors and writers through his entrepreneurial endeavours.

Like this: